These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10711852)

  • 1. Oral cancer chemotherapy in paediatric patients: obstacles and potential for development and utilisation.
    Bleyer WA; Danielson MG
    Drugs; 1999; 58 Suppl 3():133-40. PubMed ID: 10711852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral chemotherapy: rationale and future directions.
    DeMario MD; Ratain MJ
    J Clin Oncol; 1998 Jul; 16(7):2557-67. PubMed ID: 9667278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to therapy with oral antineoplastic agents.
    Partridge AH; Avorn J; Wang PS; Winer EP
    J Natl Cancer Inst; 2002 May; 94(9):652-61. PubMed ID: 11983753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral chemotherapy agents in the treatment of leukaemia.
    Geller RB; Dix SP
    Drugs; 1999; 58 Suppl 3():109-18. PubMed ID: 10711849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the changing paradigm in cancer treatment: oral chemotherapy.
    Aisner J
    Am J Health Syst Pharm; 2007 May; 64(9 Suppl 5):S4-7. PubMed ID: 17468157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient adherence and persistence with oral anticancer treatment.
    Ruddy K; Mayer E; Partridge A
    CA Cancer J Clin; 2009; 59(1):56-66. PubMed ID: 19147869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer oral therapy: emerging related issues.
    Banna GL; Collovà E; Gebbia V; Lipari H; Giuffrida P; Cavallaro S; Condorelli R; Buscarino C; Tralongo P; Ferraù F
    Cancer Treat Rev; 2010 Dec; 36(8):595-605. PubMed ID: 20570443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic and clinical outcomes in oncology using oral chemotherapy.
    Navarro RP; Morrow T; Baran R
    Manag Care Interface; 2002 Jul; 15(7):55-62. PubMed ID: 12143298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions and experiences of patients receiving oral chemotherapy.
    Simchowitz B; Shiman L; Spencer J; Brouillard D; Gross A; Connor M; Weingart SN
    Clin J Oncol Nurs; 2010 Aug; 14(4):447-53. PubMed ID: 20682500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (Hycamtin).
    Gerrits CJ; Schellens JH; Burris H; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Von Hoff DD; Verweij J
    Clin Cancer Res; 1999 Jan; 5(1):69-75. PubMed ID: 9918204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving role of oral chemotherapy for the treatment of patients with neoplasms.
    Greco FA
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 4):43-50. PubMed ID: 9556783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are patients on oral chemotherapy in your practice setting safe?
    Moody M; Jackowski J
    Clin J Oncol Nurs; 2010 Jun; 14(3):339-46. PubMed ID: 20529795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral cancer chemotherapy: the critical interplay between patient education and patient safety.
    Halfdanarson TR; Jatoi A
    Curr Oncol Rep; 2010 Jul; 12(4):247-52. PubMed ID: 20437116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing oral chemotherapy: the healthcare practitioner's role.
    Viele CS
    Am J Health Syst Pharm; 2007 May; 64(9 Suppl 5):S25-32. PubMed ID: 17468153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Psychometric Testing of the Turkish-Version Oral Chemotherapy Adherence Scale.
    Bagcivan G; Akbayrak N
    J Nurs Res; 2015 Dec; 23(4):243-51. PubMed ID: 26562455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nursing strategies for patients on oral chemotherapy.
    Hollywood E; Semple D
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):37-9; discussion 40. PubMed ID: 11219976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitating oral chemotherapy treatment and compliance through patient/family-focused education.
    Moore S
    Cancer Nurs; 2007; 30(2):112-22; quiz 123-4. PubMed ID: 17413776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-emetics for cancer chemotherapy-induced emesis: Potential of alternative delivery systems.
    Kraut L; Fauser AA
    Drugs; 2001; 61(11):1553-62. PubMed ID: 11577793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.